Follow-up of a Randomised Controlled Study of Surgical Peri-implantitis Treatment
Condition(s) studied
Investigational drug(s) / intervention(s)
Medium-term follow-up of peri-implantitis treatment: clinical examination
Study summary
This study is a medium-term (6-9 years) follow-up of the health of the tissues surrounding the implant which was treated for peri-implantitis (peri-implant infection) in an already completed study with a 12 month follow-up. Patients who were treated in a randomised controlled trial with a 12 month follow-up will be invited to attend for examination of the implant and an x-ray to assess the bone levels at the implant. Participants will be asked to complete a questionnaire about their overall satisfaction following treatment.
Eligibility
Primary outcome measure(s)
- Number of implants with peri-implant health — minimum 6 years
implant present + peri-implant probing depths ≤ 5 mm + absence of bleeding BOP ( 1 spot of bleeding allowed) + absence suppuration + no additional bone loss as compared to baseline measures
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| The University of Western Australia | Perth | Western Australia |
More The University of Western Australia trials in Australia
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07787962 on ClinicalTrials.gov ↗ ← All trials in Australia